Peritoneal Dialysis, Continuous Ambulatory
Showing 1 - 25 of >10,000
Comparative Study of Prognosis and QOL Between APD-RPM and CAPD
Not yet recruiting
- End-stage Renal Disease
- APD-RPM
- (no location specified)
Feb 23, 2023
End Stage Renal Disease Trial (Carry Life UF, 2.27% glucose peritoneal dialysis dwell)
Not yet recruiting
- End Stage Renal Disease
- Carry Life UF
- 2.27% glucose peritoneal dialysis dwell
- (no location specified)
May 15, 2023
Peritoneal Dialysis Trial (continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD))
Not yet recruiting
- Peritoneal Dialysis
- continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD)
- (no location specified)
Jul 3, 2022
End Stage Renal Disease Trial in Chieti (1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine, 0.7% Xylitol, 0.5% Glucose, and
Recruiting
- End Stage Renal Disease
- 1.5% Xylitol, 0.5% Glucose, and 0.02% L-carnitine
- 0.7% Xylitol, 0.5% Glucose, and 0.02% L-carnitine
-
Chieti, ItalyDepartment of Nephrology, University of Chieti
Aug 20, 2021
PDRI Rates Among CAPD Patients atTertiary University Hospital: A
Completed
- Peritoneal Dialysis-related Infection
- PDRI patients
-
Ratchathewi, Bangkok, ThailandPhramongkutklao Hospital
Jul 6, 2021
Patients With Diabetes on Peritoneal Dialysis
Not yet recruiting
- Kidney Disease, Chronic
- +2 more
- (no location specified)
Oct 2, 2023
Chronic Kidney Disease 5D Trial in Beijing (peritoneal rest)
Not yet recruiting
- Chronic Kidney Disease 5D
- peritoneal rest
-
Beijing, Beijing, ChinaPeking University People's Hospital
Apr 13, 2023
Oxidative Stress, Protein-Energy Wasting, Malnutrition Trial (Oral nutritional supplementation for kidney disease)
Not yet recruiting
- Oxidative Stress
- +5 more
- Oral nutritional supplementation for kidney disease
- (no location specified)
Nov 8, 2020
Guardian Sensor 3 in Diabetes Patients on Peritoneal Dialysis
Recruiting
- Diabetes Mellitus (Diagnosis)
- +2 more
- Continuous glucose monitoring system
-
Hong Kong, None Selected, ChinaElaine Chow
Aug 2, 2021
Peritoneal Dialysis Trial in Guangzhou (Icodextrin Peritoneal Dialysis Solution, Hypertonic Dextrose solution)
Not yet recruiting
- Peritoneal Dialysis
- Icodextrin Peritoneal Dialysis Solution
- Hypertonic Dextrose solution
-
Guangzhou, Guangdong, ChinaThe First Affiliated Hospital, Sun Yat-sen University
Feb 9, 2023
Secondary Peritonitis Trial in Manzanillo, Tecoman, Colima (Peritonitis treatment placed in APD, Peritonitis treatment with one
Unknown status
- Secondary Peritonitis
- Peritonitis treatment placed in APD
- Peritonitis treatment with one exchange in CAPD
-
Manzanillo, Colima, Mexico
- +2 more
Nov 5, 2020
Continuous Ambulatory Peritoneal Dialysis Trial in George Town (Stay Safe Link (SSL), Stay Safe (STS))
Completed
- Continuous Ambulatory Peritoneal Dialysis
- Stay Safe Link (SSL)
- Stay Safe (STS)
-
George Town, Penang, MalaysiaClinical Research Centre, Penang Hospital
Oct 1, 2019
Peritoneal Dialysis-associated Peritonitis, End Stage Renal Disease Trial in Guadalajara (Effluent dialysate)
Recruiting
- Peritoneal Dialysis-associated Peritonitis
- End Stage Renal Disease
- Effluent dialysate
-
Guadalajara, Jalisco, MexicoCloudCath Investigational Site
Mar 18, 2022
End Stage Renal Disease, Peritoneal Dialysis Trial in Chiang Mai (Spironolactone, Losartan)
Unknown status
- End Stage Renal Disease
- Peritoneal Dialysis
-
Chiang Mai, ThailandPharmacoepidemiology and Statistics Research Center, Faculty of
Aug 30, 2019
Peritoneal Dialysis-associated Peritonitis Trial in Philadelphia (Vancomycin)
Completed
- Peritoneal Dialysis-associated Peritonitis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Mar 1, 2022
Persons With Type 2 Diabetes on Peritoneal Dialysis
Completed
- HbA1c
- +4 more
- Continuous glucose monitoring
- Glycaemic markers
-
Copenhagen, Denmark
- +4 more
Sep 28, 2020
Long-term Peritoneal Dialysis Patients Who Eventually Develop
Active, not recruiting
- Ultrafiltration Failure
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Feb 11, 2023
End Stage Renal Disease, Diabetes Trial in Italy (PD Solution, PD solution containing L-carnitine)
Withdrawn
- End Stage Renal Disease
- Diabetes
- PD Solution
- PD solution containing L-carnitine
-
Bari, Italy
- +7 more
Jun 24, 2019
Testing Tissue Sodium Stores in CAPD Patients-Aims 1 & 2
Completed
- End Stage Renal Disease
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 2, 2019
End Stage Renal Disease, Insulin Resistance Trial in Italy (PD solution containing glucose, PD solution containing glucose and
Completed
- End Stage Renal Disease
- Insulin Resistance
- PD solution containing glucose
- PD solution containing glucose and L-carnitine
-
Bari, Italy
- +11 more
Jun 24, 2019
End-Stage Renal Disease Trial (PD solution for nocturnal exchanges, PD solution for diurnal exchanges)
Withdrawn
- End-Stage Renal Disease
- PD solution for nocturnal exchanges
- PD solution for diurnal exchanges
- (no location specified)
Jun 24, 2019
Among Patients With Advanced Kidney Disease
Recruiting
- Chronic Kidney Diseases
- Dialysis
-
Aarhus N, DenmarkAarhus University Hospital, Department of Renal Medicine
Aug 25, 2023
Blood Pressure and Pulse Wave Velocity Measurements in
Unknown status
- End Stage Renal Disease
- +2 more
-
Thessaloniki, GreeceAHEPA University Hospital
Jan 6, 2020
End-stage Renal Disease (ESRD), Kidney Disease Trial in Ottawa (DIANEAL, EXTRANEAL)
Completed
- End-stage Renal Disease (ESRD)
- Kidney Disease
- DIANEAL
- EXTRANEAL
-
Ottawa, Ontario, CanadaOttawa Hospital Research Institute
Mar 11, 2021
End Stage Renal Disease Trial in Düsseldorf, Chieti (XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght,
Not yet recruiting
- End Stage Renal Disease
- XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght
- 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution
-
Düsseldorf, Germany
- +1 more
Mar 28, 2022